A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants
Clinical trial NCT06345794 · COMPLETED
Trial details
- NCT number
- NCT06345794
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-03
- Primary completion
- 2024-06-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.